{"id":26034,"date":"2026-07-06T00:10:00","date_gmt":"2026-07-06T00:10:00","guid":{"rendered":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/"},"modified":"2026-07-06T00:10:00","modified_gmt":"2026-07-06T00:10:00","slug":"%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0","status":"publish","type":"post","link":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/","title":{"rendered":"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242"},"content":{"rendered":"

–\u00a0 ASC36_35 FDC\u662f\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u7684ASC36\u548cASC35\u7684\u590d\u65b9\u5236\u5242\uff0c\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u8fd9\u4e09\u4e2a\u5df2\u9a8c\u8bc1\u7684\u9776\u70b9\u7684\u540c\u7c7b\u9996\u521b\uff08first-in-class\uff09\u5019\u9009\u836f\u7269\u3002<\/p>\n

–\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002<\/p>\n

–\u00a0 ASC36\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684\u540c\u7c7b\u9996\u521b\u3001\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u5242\u3002<\/p>\n

–\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002<\/p>\n

\u9999\u6e2f<\/span>2026\u5e747\u67086\u65e5<\/span> \/\u7f8e\u901a\u793e\/ — \u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a1672\uff0c\u7b80\u79f0”\u6b4c\u793c”\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u8fd1\u671f\u5df2\u5411\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u9012\u4ea4\u4e86\u4e24\u9879\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08IND\uff09\uff1a<\/span>\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u65b0\u4e00\u4ee3\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242ASC36\uff0c\u4ee5\u53caASC36_35 FDC\uff0c\u5373ASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684\u6bcf\u6708\u4e00\u6b21\u6ce8\u5c04\u590d\u65b9\u5236\u5242\uff0c\u7528\u4e8e\u6cbb\u7597\u80a5\u80d6\u75c7\u3002<\/p>\n

\n

\n <\/a><\/p>\n

\n <\/p>\n<\/div>\n

“Eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u8fd1\u671f\u6570\u636e\u663e\u793a\uff0c\u5728\u7b2c32\u5468\u65f6\u4f53\u91cd\u4e0b\u964d\u4e3a29.0%[1]\u3002\u7136\u800c\uff0c\u8be5\u65b9\u6848\u9700\u8981\u6bcf\u5468\u6ce8\u5c04\u4e24\u9488\uff0c\u4e00\u9488eloralintide\uff0c\u53e6\u4e00\u9488\u66ff\u5c14\u6cca\u80bd\u3002\u800c\u6709\u671b\u6210\u4e3a\u540c\u7c7b\u9996\u521b\u3001\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u7684\u76ae\u4e0b\u6ce8\u5c04\u590d\u65b9\u5236\u5242ASC36_35 FDC\uff0c\u6bcf\u6708\u4ec5\u9700\u6ce8\u5c04\u4e00\u6b21\uff0c”\u6b4c\u793c\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u4f1a\u4e3b\u5e2d\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5434\u52b2\u6893\u535a\u58eb\u8868\u793a\uff0c”\u540c\u6837\u4ee4\u4eba\u632f\u594b\u7684\u662f\uff0c\u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002\u8fd9\u4e9b\u52a8\u7269\u6a21\u578b\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\u3002”<\/p>\n

ASC36\u548cASC35\u5747\u662f\u6b4c\u793c\u5229\u7528\u5176\u57fa\u4e8e\u7ed3\u6784\u7684AI\u8f85\u52a9\u836f\u7269\u53d1\u73b0\uff08AISBDD\uff09\u6280\u672f\u81ea\u4e3b\u7814\u53d1\u7684\u3002ASC36\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u5236\u5242\u4ee5\u53caASC36_35 FDC\u6bcf\u6708\u4e00\u6b21\u590d\u65b9\u5236\u5242\u5747\u4e3a\u81ea\u7ec4\u88c5\u8102\u8d28\u50a8\u5e93\u578b\uff08SALD\uff09\u5236\u5242\uff0c\u5229\u7528\u6b4c\u793c\u4e13\u6709\u7684\u8d85\u957f\u6548\u836f\u7269\u5f00\u53d1\u5e73\u53f0\uff08ULAP\uff09\u6280\u672f\u5f00\u53d1\u800c\u6210\u3002<\/p>\n

\u5728\u5934\u5bf9\u5934\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36 SALD\u5236\u5242\u7684\u8868\u89c2\u534a\u8870\u671f\uff08observed half-life\uff09\u7ea6\u4e3aeloralintide\u76846\u500d\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002\u5728\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36\u548cASC35\u4e24\u8005\u5728ASC36_35 FDC SALD\u5236\u5242\u4e2d\u5747\u5177\u6709\u8f83\u957f\u7684\u8868\u89c2\u534a\u8870\u671f\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002<\/p>\n

\u4e34\u5e8a\u524d\u7814\u7a76\u5df2\u786e\u7acb\u4e86ASC36\u6ce8\u5c04\u5242\u53caASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u7684\u4f18\u8d8a\u7597\u6548\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff08\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\uff09\uff0c\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684ASC36\u5355\u836f\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35\u590d\u65b9\u5236\u5242\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u4e09\u4e2a\u9776\u70b9\uff0c\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002<\/p>\n

ASC36\u6ce8\u5c04\u5242\u548cASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u5177\u6709\u4f18\u8d8a\u7684\u7406\u5316\u7a33\u5b9a\u6027\uff0c\u5728\u4e2d\u6027pH\u503c\u9644\u8fd1\u6ca1\u6709\u7ea4\u7ef4\u5316\u5bfc\u81f4\u7684\u805a\u96c6\u6c89\u6dc0\u3002<\/p>\n

\u5728ASC35 SALD\u6708\u5236\u5242\u8fd1\u671f\u53d6\u5f97\u7684\u91cc\u7a0b\u7891\u57fa\u7840\u4e0a\uff0c\u6211\u4eec\u5df2\u9012\u4ea4ASC36\u6708\u6ce8\u5c04\u5242\u53caASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242\u4e24\u9879IND\u30022026\u5e746\u6708\uff0c\u6b4c\u793c\u5ba3\u5e03\u5176\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04ASC35\u6cbb\u7597\u80a5\u80d6\u75c7\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u7f8e\u56fdFDA\u7684IND\u6279\u51c6\uff08\u65b0\u95fb\u53d1\u5e03<\/a>\uff09\uff0c\u5f70\u663e\u4e86\u516c\u53f8\u5f3a\u52b2\u7684\u4e34\u5e8a\u5f00\u53d1\u6267\u884c\u529b\u53ca\u5176ULAP\u6280\u672f\u7684\u6f5c\u529b\u3002<\/p>\n

[1] Eli Lilly and Company. Safety, tolerability, pharmacokinetics and pharmacodynamics of eloralintide and tirzepatide co-administered as once-weekly subcutaneous injections [Abstract accepted for presentation at EASD 2026<\/a>]<\/p>\n

\u5173\u4e8e\u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8<\/p>\n

\u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u5168\u4ef7\u503c\u94fe\u6574\u5408\u578b\u751f\u7269\u6280\u672f\u516c\u53f8\uff0c\u805a\u7126\u6709\u671b\u6210\u4e3a\u6cbb\u7597\u4ee3\u8c22\u75be\u75c5\u540c\u7c7b\u6700\u4f73\uff08best-in-class\uff09\u548c\u540c\u7c7b\u9996\u521b\uff08first-in-class\uff09\u836f\u7269\u7684\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u3002\u5229\u7528\u516c\u53f8\u4e13\u6709\u7684\u57fa\u4e8e\u7ed3\u6784\u7684AI\u8f85\u52a9\u836f\u7269\u53d1\u73b0\uff08Artificial Intelligence-assisted Structure-Based Drug Discovery\uff0cAISBDD\uff09\u3001\u8d85\u957f\u6548\u836f\u7269\u5f00\u53d1\u5e73\u53f0\uff08Ultra-Long-Acting Platform\uff0cULAP\uff09\u6280\u672f\u4ee5\u53ca\u53e3\u670d\u591a\u80bd\u9012\u9001\u589e\u5f3a\u6280\u672f\uff08Peptide Oral Transport ENhancement Technology\uff0cPOTENT\uff09\uff0c\u6b4c\u793c\u5df2\u81ea\u4e3b\u7814\u53d1\u591a\u6b3e\u5c0f\u5206\u5b50\u548c\u591a\u80bd\u5019\u9009\u836f\u7269\uff0c\u5305\u62ec\u5176\u6838\u5fc3\u9879\u76eeASC30\uff0c\u4e00\u6b3e\u5728\u7814\u5c0f\u5206\u5b50GLP-1R\u6fc0\u52a8\u5242\uff0c\u65e2\u53ef\u6bcf\u65e5\u4e00\u6b21\u53e3\u670d\u4e5f\u53ef\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u4f5c\u4e3a\u51cf\u91cd\u6cbb\u7597\u7597\u6cd5\u548c\u51cf\u91cd\u7ef4\u6301\u7597\u6cd5\uff0c\u7528\u4e8e\u957f\u671f\u4f53\u91cd\u7ba1\u7406\uff1bASC36\uff0c\u4e00\u6b3e\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u591a\u80bd\uff0cASC35\uff0c\u4e00\u6b3e\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04GLP-1R\/GIPR\u53cc\u9776\u70b9\u6fc0\u52a8\u5242\u591a\u80bd\uff0cASC37\uff0c\u4e00\u6b3eGLP-1R\/GIPR\/GCGR\u4e09\u9776\u70b9\u6fc0\u52a8\u5242\u591a\u80bd\uff0cASC39\uff0c\u4e00\u6b3e\u7c7b\u4f3celoralintide\u3001\u5bf9\u80f0\u6dc0\u7d20\u5177\u6709\u9009\u62e9\u6027\u7684\u5f3a\u6548\u53e3\u670d\u5c0f\u5206\u5b50\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\uff0c\u548cASC30_39 FDC\uff0cASC30\uff08GLP-1RA\uff09\u4e0eASC39\uff08\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\uff09\u7684\u56fa\u5b9a\u5242\u91cf\u590d\u65b9\u5236\u5242\uff08FDC\uff09\uff0c\u7528\u4e8e\u957f\u671f\u4f53\u91cd\u7ba1\u7406\u3002\u6b4c\u793c\u5df2\u5728\u9999\u6e2f\u8054\u4ea4\u6240\u4e0a\u5e02\uff081672.HK\uff09\u3002<\/p>\n

\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u656c\u8bf7\u767b\u5f55\u7f51\u7ad9\uff1awww.ascletis.com<\/a>\u3002<\/p>\n

\u8be6\u60c5\u5782\u8be2\uff1a<\/p>\n

Peter Vozzo
ICR Healthcare
443-231-0505 (\u7f8e\u56fd)
Peter.vozzo@icrhealthcare.com<\/a><\/p>\n

\u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8PR\u548cIR\u56e2\u961f
+86-181-0650-9129 (\u4e2d\u56fd)
pr@ascletis.com<\/a>
ir@ascletis.com<\/a><\/p>\n

SOURCE \u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8<\/p>","protected":false},"excerpt":{"rendered":"

–\u00a0 ASC36_35 FDC\u662f\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u7684ASC36\u548cASC35\u7684\u590d\u65b9\u5236\u5242\uff0c\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u8fd9\u4e09\u4e2a\u5df2\u9a8c\u8bc1\u7684\u9776\u70b9\u7684\u540c\u7c7b\u9996\u521b\uff08first-in-class\uff09\u5019\u9009\u836f\u7269\u3002 –\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002 –\u00a0 ASC36\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684\u540c\u7c7b\u9996\u521b\u3001\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u5242\u3002 –\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002 \u9999\u6e2f2026\u5e747\u67086\u65e5 \/\u7f8e\u901a\u793e\/ — \u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a1672\uff0c\u7b80\u79f0”\u6b4c\u793c”\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u8fd1\u671f\u5df2\u5411\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u9012\u4ea4\u4e86\u4e24\u9879\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08IND\uff09\uff1a\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u65b0\u4e00\u4ee3\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242ASC36\uff0c\u4ee5\u53caASC36_35 FDC\uff0c\u5373ASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684\u6bcf\u6708\u4e00\u6b21\u6ce8\u5c04\u590d\u65b9\u5236\u5242\uff0c\u7528\u4e8e\u6cbb\u7597\u80a5\u80d6\u75c7\u3002 “Eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u8fd1\u671f\u6570\u636e\u663e\u793a\uff0c\u5728\u7b2c32\u5468\u65f6\u4f53\u91cd\u4e0b\u964d\u4e3a29.0%[1]\u3002\u7136\u800c\uff0c\u8be5\u65b9\u6848\u9700\u8981\u6bcf\u5468\u6ce8\u5c04\u4e24\u9488\uff0c\u4e00\u9488eloralintide\uff0c\u53e6\u4e00\u9488\u66ff\u5c14\u6cca\u80bd\u3002\u800c\u6709\u671b\u6210\u4e3a\u540c\u7c7b\u9996\u521b\u3001\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u7684\u76ae\u4e0b\u6ce8\u5c04\u590d\u65b9\u5236\u5242ASC36_35 FDC\uff0c\u6bcf\u6708\u4ec5\u9700\u6ce8\u5c04\u4e00\u6b21\uff0c”\u6b4c\u793c\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u4f1a\u4e3b\u5e2d\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5434\u52b2\u6893\u535a\u58eb\u8868\u793a\uff0c”\u540c\u6837\u4ee4\u4eba\u632f\u594b\u7684\u662f\uff0c\u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002\u8fd9\u4e9b\u52a8\u7269\u6a21\u578b\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\u3002” ASC36\u548cASC35\u5747\u662f\u6b4c\u793c\u5229\u7528\u5176\u57fa\u4e8e\u7ed3\u6784\u7684AI\u8f85\u52a9\u836f\u7269\u53d1\u73b0\uff08AISBDD\uff09\u6280\u672f\u81ea\u4e3b\u7814\u53d1\u7684\u3002ASC36\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u5236\u5242\u4ee5\u53caASC36_35 FDC\u6bcf\u6708\u4e00\u6b21\u590d\u65b9\u5236\u5242\u5747\u4e3a\u81ea\u7ec4\u88c5\u8102\u8d28\u50a8\u5e93\u578b\uff08SALD\uff09\u5236\u5242\uff0c\u5229\u7528\u6b4c\u793c\u4e13\u6709\u7684\u8d85\u957f\u6548\u836f\u7269\u5f00\u53d1\u5e73\u53f0\uff08ULAP\uff09\u6280\u672f\u5f00\u53d1\u800c\u6210\u3002 \u5728\u5934\u5bf9\u5934\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36 SALD\u5236\u5242\u7684\u8868\u89c2\u534a\u8870\u671f\uff08observed half-life\uff09\u7ea6\u4e3aeloralintide\u76846\u500d\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002\u5728\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36\u548cASC35\u4e24\u8005\u5728ASC36_35 FDC SALD\u5236\u5242\u4e2d\u5747\u5177\u6709\u8f83\u957f\u7684\u8868\u89c2\u534a\u8870\u671f\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002 \u4e34\u5e8a\u524d\u7814\u7a76\u5df2\u786e\u7acb\u4e86ASC36\u6ce8\u5c04\u5242\u53caASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u7684\u4f18\u8d8a\u7597\u6548\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff08\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\uff09\uff0c\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684ASC36\u5355\u836f\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35\u590d\u65b9\u5236\u5242\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u4e09\u4e2a\u9776\u70b9\uff0c\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002 ASC36\u6ce8\u5c04\u5242\u548cASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u5177\u6709\u4f18\u8d8a\u7684\u7406\u5316\u7a33\u5b9a\u6027\uff0c\u5728\u4e2d\u6027pH\u503c\u9644\u8fd1\u6ca1\u6709\u7ea4\u7ef4\u5316\u5bfc\u81f4\u7684\u805a\u96c6\u6c89\u6dc0\u3002 \u5728ASC35 SALD\u6708\u5236\u5242\u8fd1\u671f\u53d6\u5f97\u7684\u91cc\u7a0b\u7891\u57fa\u7840\u4e0a\uff0c\u6211\u4eec\u5df2\u9012\u4ea4ASC36\u6708\u6ce8\u5c04\u5242\u53caASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242\u4e24\u9879IND\u30022026\u5e746\u6708\uff0c\u6b4c\u793c\u5ba3\u5e03\u5176\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04ASC35\u6cbb\u7597\u80a5\u80d6\u75c7\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u7f8e\u56fdFDA\u7684IND\u6279\u51c6\uff08\u65b0\u95fb\u53d1\u5e03\uff09\uff0c\u5f70\u663e\u4e86\u516c\u53f8\u5f3a\u52b2\u7684\u4e34\u5e8a\u5f00\u53d1\u6267\u884c\u529b\u53ca\u5176ULAP\u6280\u672f\u7684\u6f5c\u529b\u3002 [1] Eli Lilly and Company. Safety, tolerability, pharmacokinetics and pharmacodynamics of eloralintide and tirzepatide co-administered as once-weekly subcutaneous injections [Abstract accepted for presentation at […]<\/p>\n","protected":false},"author":0,"featured_media":26035,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-26034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"\n\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242 - Money Compass CN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/moneycompass.com.my\/cn\/\u6b4c\u793c\u5411\u7f8e\u56fdfda\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684ind\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242 - Money Compass CN\" \/>\n<meta property=\"og:description\" content=\"–\u00a0 ASC36_35 FDC\u662f\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u7684ASC36\u548cASC35\u7684\u590d\u65b9\u5236\u5242\uff0c\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u8fd9\u4e09\u4e2a\u5df2\u9a8c\u8bc1\u7684\u9776\u70b9\u7684\u540c\u7c7b\u9996\u521b\uff08first-in-class\uff09\u5019\u9009\u836f\u7269\u3002 –\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002 –\u00a0 ASC36\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684\u540c\u7c7b\u9996\u521b\u3001\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u5242\u3002 –\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002 \u9999\u6e2f2026\u5e747\u67086\u65e5 \/\u7f8e\u901a\u793e\/ — \u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a1672\uff0c\u7b80\u79f0”\u6b4c\u793c”\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u8fd1\u671f\u5df2\u5411\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u9012\u4ea4\u4e86\u4e24\u9879\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08IND\uff09\uff1a\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u65b0\u4e00\u4ee3\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242ASC36\uff0c\u4ee5\u53caASC36_35 FDC\uff0c\u5373ASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684\u6bcf\u6708\u4e00\u6b21\u6ce8\u5c04\u590d\u65b9\u5236\u5242\uff0c\u7528\u4e8e\u6cbb\u7597\u80a5\u80d6\u75c7\u3002 “Eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u8fd1\u671f\u6570\u636e\u663e\u793a\uff0c\u5728\u7b2c32\u5468\u65f6\u4f53\u91cd\u4e0b\u964d\u4e3a29.0%[1]\u3002\u7136\u800c\uff0c\u8be5\u65b9\u6848\u9700\u8981\u6bcf\u5468\u6ce8\u5c04\u4e24\u9488\uff0c\u4e00\u9488eloralintide\uff0c\u53e6\u4e00\u9488\u66ff\u5c14\u6cca\u80bd\u3002\u800c\u6709\u671b\u6210\u4e3a\u540c\u7c7b\u9996\u521b\u3001\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u7684\u76ae\u4e0b\u6ce8\u5c04\u590d\u65b9\u5236\u5242ASC36_35 FDC\uff0c\u6bcf\u6708\u4ec5\u9700\u6ce8\u5c04\u4e00\u6b21\uff0c”\u6b4c\u793c\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u4f1a\u4e3b\u5e2d\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5434\u52b2\u6893\u535a\u58eb\u8868\u793a\uff0c”\u540c\u6837\u4ee4\u4eba\u632f\u594b\u7684\u662f\uff0c\u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002\u8fd9\u4e9b\u52a8\u7269\u6a21\u578b\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\u3002” ASC36\u548cASC35\u5747\u662f\u6b4c\u793c\u5229\u7528\u5176\u57fa\u4e8e\u7ed3\u6784\u7684AI\u8f85\u52a9\u836f\u7269\u53d1\u73b0\uff08AISBDD\uff09\u6280\u672f\u81ea\u4e3b\u7814\u53d1\u7684\u3002ASC36\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u5236\u5242\u4ee5\u53caASC36_35 FDC\u6bcf\u6708\u4e00\u6b21\u590d\u65b9\u5236\u5242\u5747\u4e3a\u81ea\u7ec4\u88c5\u8102\u8d28\u50a8\u5e93\u578b\uff08SALD\uff09\u5236\u5242\uff0c\u5229\u7528\u6b4c\u793c\u4e13\u6709\u7684\u8d85\u957f\u6548\u836f\u7269\u5f00\u53d1\u5e73\u53f0\uff08ULAP\uff09\u6280\u672f\u5f00\u53d1\u800c\u6210\u3002 \u5728\u5934\u5bf9\u5934\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36 SALD\u5236\u5242\u7684\u8868\u89c2\u534a\u8870\u671f\uff08observed half-life\uff09\u7ea6\u4e3aeloralintide\u76846\u500d\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002\u5728\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36\u548cASC35\u4e24\u8005\u5728ASC36_35 FDC SALD\u5236\u5242\u4e2d\u5747\u5177\u6709\u8f83\u957f\u7684\u8868\u89c2\u534a\u8870\u671f\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002 \u4e34\u5e8a\u524d\u7814\u7a76\u5df2\u786e\u7acb\u4e86ASC36\u6ce8\u5c04\u5242\u53caASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u7684\u4f18\u8d8a\u7597\u6548\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff08\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\uff09\uff0c\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684ASC36\u5355\u836f\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35\u590d\u65b9\u5236\u5242\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u4e09\u4e2a\u9776\u70b9\uff0c\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002 ASC36\u6ce8\u5c04\u5242\u548cASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u5177\u6709\u4f18\u8d8a\u7684\u7406\u5316\u7a33\u5b9a\u6027\uff0c\u5728\u4e2d\u6027pH\u503c\u9644\u8fd1\u6ca1\u6709\u7ea4\u7ef4\u5316\u5bfc\u81f4\u7684\u805a\u96c6\u6c89\u6dc0\u3002 \u5728ASC35 SALD\u6708\u5236\u5242\u8fd1\u671f\u53d6\u5f97\u7684\u91cc\u7a0b\u7891\u57fa\u7840\u4e0a\uff0c\u6211\u4eec\u5df2\u9012\u4ea4ASC36\u6708\u6ce8\u5c04\u5242\u53caASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242\u4e24\u9879IND\u30022026\u5e746\u6708\uff0c\u6b4c\u793c\u5ba3\u5e03\u5176\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04ASC35\u6cbb\u7597\u80a5\u80d6\u75c7\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u7f8e\u56fdFDA\u7684IND\u6279\u51c6\uff08\u65b0\u95fb\u53d1\u5e03\uff09\uff0c\u5f70\u663e\u4e86\u516c\u53f8\u5f3a\u52b2\u7684\u4e34\u5e8a\u5f00\u53d1\u6267\u884c\u529b\u53ca\u5176ULAP\u6280\u672f\u7684\u6f5c\u529b\u3002 [1] Eli Lilly and Company. Safety, tolerability, pharmacokinetics and pharmacodynamics of eloralintide and tirzepatide co-administered as once-weekly subcutaneous injections [Abstract accepted for presentation at […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/moneycompass.com.my\/cn\/\u6b4c\u793c\u5411\u7f8e\u56fdfda\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684ind\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\/\" \/>\n<meta property=\"og:site_name\" content=\"Money Compass CN\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-06T00:10:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/\",\"name\":\"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242 - Money Compass CN\",\"isPartOf\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2026\/07\/Ascletis_Pharma_Logo-2biIwf.jpeg\",\"datePublished\":\"2026-07-06T00:10:00+00:00\",\"dateModified\":\"2026-07-06T00:10:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#primaryimage\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2026\/07\/Ascletis_Pharma_Logo-2biIwf.jpeg\",\"contentUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2026\/07\/Ascletis_Pharma_Logo-2biIwf.jpeg\",\"width\":144,\"height\":56},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/moneycompass.com.my\/cn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/\",\"name\":\"Money Compass CN\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242 - Money Compass CN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/moneycompass.com.my\/cn\/\u6b4c\u793c\u5411\u7f8e\u56fdfda\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684ind\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\/","og_locale":"en_US","og_type":"article","og_title":"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242 - Money Compass CN","og_description":"–\u00a0 ASC36_35 FDC\u662f\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u7684ASC36\u548cASC35\u7684\u590d\u65b9\u5236\u5242\uff0c\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u8fd9\u4e09\u4e2a\u5df2\u9a8c\u8bc1\u7684\u9776\u70b9\u7684\u540c\u7c7b\u9996\u521b\uff08first-in-class\uff09\u5019\u9009\u836f\u7269\u3002 –\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002 –\u00a0 ASC36\u6709\u671b\u6210\u4e3a\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684\u540c\u7c7b\u9996\u521b\u3001\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04\u5242\u3002 –\u00a0 \u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002 \u9999\u6e2f2026\u5e747\u67086\u65e5 \/\u7f8e\u901a\u793e\/ — \u6b4c\u793c\u5236\u836f\u6709\u9650\u516c\u53f8\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a1672\uff0c\u7b80\u79f0”\u6b4c\u793c”\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u8fd1\u671f\u5df2\u5411\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u9012\u4ea4\u4e86\u4e24\u9879\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08IND\uff09\uff1a\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u65b0\u4e00\u4ee3\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242ASC36\uff0c\u4ee5\u53caASC36_35 FDC\uff0c\u5373ASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684\u6bcf\u6708\u4e00\u6b21\u6ce8\u5c04\u590d\u65b9\u5236\u5242\uff0c\u7528\u4e8e\u6cbb\u7597\u80a5\u80d6\u75c7\u3002 “Eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u8fd1\u671f\u6570\u636e\u663e\u793a\uff0c\u5728\u7b2c32\u5468\u65f6\u4f53\u91cd\u4e0b\u964d\u4e3a29.0%[1]\u3002\u7136\u800c\uff0c\u8be5\u65b9\u6848\u9700\u8981\u6bcf\u5468\u6ce8\u5c04\u4e24\u9488\uff0c\u4e00\u9488eloralintide\uff0c\u53e6\u4e00\u9488\u66ff\u5c14\u6cca\u80bd\u3002\u800c\u6709\u671b\u6210\u4e3a\u540c\u7c7b\u9996\u521b\u3001\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u7684\u76ae\u4e0b\u6ce8\u5c04\u590d\u65b9\u5236\u5242ASC36_35 FDC\uff0c\u6bcf\u6708\u4ec5\u9700\u6ce8\u5c04\u4e00\u6b21\uff0c”\u6b4c\u793c\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u4f1a\u4e3b\u5e2d\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5434\u52b2\u6893\u535a\u58eb\u8868\u793a\uff0c”\u540c\u6837\u4ee4\u4eba\u632f\u594b\u7684\u662f\uff0c\u5728\u5934\u5bf9\u5934\u996e\u98df\u8bf1\u5bfc\u80a5\u80d6\uff08DIO\uff09\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35 FDC\u7684\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002\u8fd9\u4e9b\u52a8\u7269\u6a21\u578b\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\u3002” ASC36\u548cASC35\u5747\u662f\u6b4c\u793c\u5229\u7528\u5176\u57fa\u4e8e\u7ed3\u6784\u7684AI\u8f85\u52a9\u836f\u7269\u53d1\u73b0\uff08AISBDD\uff09\u6280\u672f\u81ea\u4e3b\u7814\u53d1\u7684\u3002ASC36\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u5236\u5242\u4ee5\u53caASC36_35 FDC\u6bcf\u6708\u4e00\u6b21\u590d\u65b9\u5236\u5242\u5747\u4e3a\u81ea\u7ec4\u88c5\u8102\u8d28\u50a8\u5e93\u578b\uff08SALD\uff09\u5236\u5242\uff0c\u5229\u7528\u6b4c\u793c\u4e13\u6709\u7684\u8d85\u957f\u6548\u836f\u7269\u5f00\u53d1\u5e73\u53f0\uff08ULAP\uff09\u6280\u672f\u5f00\u53d1\u800c\u6210\u3002 \u5728\u5934\u5bf9\u5934\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36 SALD\u5236\u5242\u7684\u8868\u89c2\u534a\u8870\u671f\uff08observed half-life\uff09\u7ea6\u4e3aeloralintide\u76846\u500d\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u81f3\u6bcf\u5b63\u5ea6\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002\u5728\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u7814\u7a76\u4e2d\uff0cASC36\u548cASC35\u4e24\u8005\u5728ASC36_35 FDC SALD\u5236\u5242\u4e2d\u5747\u5177\u6709\u8f83\u957f\u7684\u8868\u89c2\u534a\u8870\u671f\uff0c\u652f\u6301\u5728\u4eba\u4f53\u4e2d\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u7ed9\u836f\u3002 \u4e34\u5e8a\u524d\u7814\u7a76\u5df2\u786e\u7acb\u4e86ASC36\u6ce8\u5c04\u5242\u53caASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u7684\u4f18\u8d8a\u7597\u6548\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff08\u5bf9\u4eba\u4f53\u7597\u6548\u5177\u6709\u9ad8\u5ea6\u9884\u6d4b\u6027\uff09\uff0c\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u7684ASC36\u5355\u836f\u8f83petrelintide\u5355\u836f\u548celoralintide\u5355\u836f\u7684\u51cf\u91cd\u6548\u679c\u5206\u522b\u76f8\u5bf9\u63d0\u5347\u7ea691%\u548c32%\u3002\u5728\u5934\u5bf9\u5934DIO\u5927\u9f20\u7814\u7a76\u4e2d\uff0cASC36_35\u590d\u65b9\u5236\u5242\u9776\u5411\u80f0\u6dc0\u7d20\u53d7\u4f53\u3001GLP-1R\u548cGIPR\u4e09\u4e2a\u9776\u70b9\uff0c\u51cf\u91cd\u6548\u679c\u8f83eloralintide\u8054\u5408\u66ff\u5c14\u6cca\u80bd\u76f8\u5bf9\u63d0\u5347\u7ea651%\u3002 ASC36\u6ce8\u5c04\u5242\u548cASC36_35 FDC\u590d\u65b9\u6ce8\u5c04\u5242\u5177\u6709\u4f18\u8d8a\u7684\u7406\u5316\u7a33\u5b9a\u6027\uff0c\u5728\u4e2d\u6027pH\u503c\u9644\u8fd1\u6ca1\u6709\u7ea4\u7ef4\u5316\u5bfc\u81f4\u7684\u805a\u96c6\u6c89\u6dc0\u3002 \u5728ASC35 SALD\u6708\u5236\u5242\u8fd1\u671f\u53d6\u5f97\u7684\u91cc\u7a0b\u7891\u57fa\u7840\u4e0a\uff0c\u6211\u4eec\u5df2\u9012\u4ea4ASC36\u6708\u6ce8\u5c04\u5242\u53caASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242\u4e24\u9879IND\u30022026\u5e746\u6708\uff0c\u6b4c\u793c\u5ba3\u5e03\u5176\u6bcf\u6708\u4e00\u6b21\u76ae\u4e0b\u6ce8\u5c04ASC35\u6cbb\u7597\u80a5\u80d6\u75c7\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u7f8e\u56fdFDA\u7684IND\u6279\u51c6\uff08\u65b0\u95fb\u53d1\u5e03\uff09\uff0c\u5f70\u663e\u4e86\u516c\u53f8\u5f3a\u52b2\u7684\u4e34\u5e8a\u5f00\u53d1\u6267\u884c\u529b\u53ca\u5176ULAP\u6280\u672f\u7684\u6f5c\u529b\u3002 [1] Eli Lilly and Company. Safety, tolerability, pharmacokinetics and pharmacodynamics of eloralintide and tirzepatide co-administered as once-weekly subcutaneous injections [Abstract accepted for presentation at […]","og_url":"https:\/\/moneycompass.com.my\/cn\/\u6b4c\u793c\u5411\u7f8e\u56fdfda\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684ind\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\/","og_site_name":"Money Compass CN","article_published_time":"2026-07-06T00:10:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/","url":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/","name":"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242 - Money Compass CN","isPartOf":{"@id":"https:\/\/moneycompass.com.my\/cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#primaryimage"},"image":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#primaryimage"},"thumbnailUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2026\/07\/Ascletis_Pharma_Logo-2biIwf.jpeg","datePublished":"2026-07-06T00:10:00+00:00","dateModified":"2026-07-06T00:10:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#primaryimage","url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2026\/07\/Ascletis_Pharma_Logo-2biIwf.jpeg","contentUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2026\/07\/Ascletis_Pharma_Logo-2biIwf.jpeg","width":144,"height":56},{"@type":"BreadcrumbList","@id":"https:\/\/moneycompass.com.my\/cn\/%e6%ad%8c%e7%a4%bc%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a%e5%a4%9a%e8%82%bd%e8%83%b0\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/moneycompass.com.my\/cn\/"},{"@type":"ListItem","position":2,"name":"\u6b4c\u793c\u5411\u7f8e\u56fdFDA\u9012\u4ea4\u4e24\u9879\u6cbb\u7597\u80a5\u80d6\u75c7\u7684IND\u7533\u8bf7\uff1a\u591a\u80bd\u80f0\u6dc0\u7d20\u53d7\u4f53\u6fc0\u52a8\u5242\u6708\u6ce8\u5c04\u5242ASC36\u4ee5\u53caASC36\u8054\u5408\u591a\u80bdGLP-1R\/GIPR\u6fc0\u52a8\u5242ASC35\u7684ASC36_35\u590d\u65b9\u6708\u6ce8\u5c04\u5242"}]},{"@type":"WebSite","@id":"https:\/\/moneycompass.com.my\/cn\/#website","url":"https:\/\/moneycompass.com.my\/cn\/","name":"Money Compass CN","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/26034"}],"collection":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/comments?post=26034"}],"version-history":[{"count":0,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/26034\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media\/26035"}],"wp:attachment":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media?parent=26034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/categories?post=26034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/tags?post=26034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}